Bristol-Myers Squibb Company (LON:0R1F)

London flag London · Delayed Price · Currency is GBP · Price in USD
59.10
+0.23 (0.39%)
At close: Mar 28, 2025
12.63%
Market Cap 92.22B
Revenue (ttm) 38.58B
Net Income (ttm) -7.15B
Shares Out n/a
EPS (ttm) -3.53
PE Ratio n/a
Forward PE n/a
Dividend 1.90 (2.61%)
Ex-Dividend Date Apr 4, 2025
Volume 1,403
Average Volume 9,617
Open 59.25
Previous Close 58.87
Day's Range 58.25 - 59.40
52-Week Range 57.97 - 81.40
Beta 0.44
RSI 47.89
Earnings Date Apr 24, 2025

About LON:0R1F

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R1F
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.